Adverum Biotechnologies Inc
NASDAQ:ADVM

Watchlist Manager
Adverum Biotechnologies Inc Logo
Adverum Biotechnologies Inc
NASDAQ:ADVM
Watchlist
Price: 8.04 USD -2.55% Market Closed
Updated: May 18, 2024

Adverum Biotechnologies Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Adverum Biotechnologies Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Adverum Biotechnologies Inc
NASDAQ:ADVM
Total Other Income
$6.6m
CAGR 3-Years
95%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Other Income
-$3.5B
CAGR 3-Years
12%
CAGR 5-Years
-62%
CAGR 10-Years
-78%
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$158m
CAGR 3-Years
4%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$151m
CAGR 3-Years
126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$55.2m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
-$31.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Adverum Biotechnologies Inc's Total Other Income?
Total Other Income
6.6m USD

Based on the financial report for Mar 31, 2024, Adverum Biotechnologies Inc's Total Other Income amounts to 6.6m USD.

What is Adverum Biotechnologies Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
7%

Over the last year, the Total Other Income growth was 82%. The average annual Total Other Income growth rates for Adverum Biotechnologies Inc have been 95% over the past three years , 7% over the past five years .